News Source: Androscoggin News
| 6 months ago
A vaccine designed to treat patients with advanced melanoma has shown promise in a new study. In a new late-stage clinical trial, researchers found that using the peptide vaccine along with the immunotherapy drug Interleukin-2 improved response rates...
News Source: Uinta County News
| 6 months ago
Biovest International Inc. said a Phase III clinical study has shown that BiovaxID significantly prolonged disease-free survival in follicular non-Hodgkin’s lymphoma. The study was featured at the American Society of Clinical Oncology ’s annual...
News Source: Press TV
| 6 months ago
Previous studies had reported bevacizumab (Avastin) and erlotinib (Tarceva) as effective medications in blocking the tumor growth in non-small cell lung cancer. A new study, however, showed adding erlotinib to maintenance therapy with bevacizumab in...
News Source: Pak Tribune
| 6 months ago
Women taking anti-cancer drug tamoxifen may have their disease come back if they use with it certain antidepressants, according to a new research. Tumors were more than twice as likely to return after two years in women taking the antidepressants...
News Source: BBC
| 6 months ago
Scientists say they have developed a drug that can treat the most deadly form of skin cancer in its most advanced, incurable stages. Malignant melanoma is the most rapidly increasing cancer in the UK, largely due to sun exposure. An experimental drug...
News Source: Uinta County News
| 6 months ago
For the medical world, new research means another open door for fighting cancer...Dr. Doug Schwartzentruber from the Goshen Cancer Center is heading a research project on a new vaccine to treat patients with metastatic melanoma...If it spreads into...